Continuous AMD3100 Treatment Worsens Renal Fibrosis through Regulation of Bone Marrow Derived Pro-Angiogenic Cells Homing and T-Cell-Related Inflammation

AMD3100 is a small molecule inhibitor of chemokine receptor type 4 (CXCR4), which is located in the cell membranes of CD34+ cells and a variety of inflammatory cells and has been reported to reduce organ fibrosis in the lung, liver and myocardium. However, the effect of AMD3100 on renal fibrosis is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Yang, Juan, Zhu, Fengming, Wang, Xiaohui, Yao, Weiqi, Wang, Meng, Pei, Guangchang, Hu, Zhizhi, Guo, Yujiao, Zhao, Zhi, Wang, Pengge, Mou, Jingyi, Sun, Jie, Zeng, Rui, Xu, Gang, Liao, Wenhui, Yao, Ying
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4763993/
https://ncbi.nlm.nih.gov/pubmed/26900858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0149926
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados